CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Vestibular neuronitis - Evidence
Evidence on symptomatic drug treatment for vestibular neuronitis
CKS found no good-quality evidence of benefit for the different symptomatic treatment options. However, the recommended drugs are all licensed for use in people with nausea, vomiting, and vertigo.
© NHS Institute for Innovation and Improvement